

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of lipoprotein metabolic process (GO:0050746) | 9.17291612 |
| 2 | negative regulation of focal adhesion assembly (GO:0051895) | 8.09096893 |
| 3 | negative regulation of cell junction assembly (GO:1901889) | 8.09096893 |
| 4 | negative regulation of adherens junction organization (GO:1903392) | 8.09096893 |
| 5 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 7.78671933 |
| 6 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 7.57727694 |
| 7 | actin-myosin filament sliding (GO:0033275) | 6.88884715 |
| 8 | muscle filament sliding (GO:0030049) | 6.88884715 |
| 9 | negative regulation of chemokine production (GO:0032682) | 5.99632167 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 5.79253294 |
| 11 | axon regeneration (GO:0031103) | 5.72215091 |
| 12 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.66558341 |
| 13 | actin-mediated cell contraction (GO:0070252) | 5.66402259 |
| 14 | positive regulation of astrocyte differentiation (GO:0048711) | 5.59033840 |
| 15 | skeletal muscle fiber development (GO:0048741) | 5.51145100 |
| 16 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 5.50489116 |
| 17 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.40650657 |
| 18 | skeletal muscle contraction (GO:0003009) | 5.15565370 |
| 19 | enteric nervous system development (GO:0048484) | 5.11080601 |
| 20 | myotube cell development (GO:0014904) | 5.09106140 |
| 21 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.96656951 |
| 22 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 4.84263475 |
| 23 | cell aggregation (GO:0098743) | 4.78820201 |
| 24 | cartilage condensation (GO:0001502) | 4.78820201 |
| 25 | myofibril assembly (GO:0030239) | 4.60850195 |
| 26 | regulation of relaxation of muscle (GO:1901077) | 4.60490321 |
| 27 | diterpenoid biosynthetic process (GO:0016102) | 4.57227964 |
| 28 | sarcomere organization (GO:0045214) | 4.46476417 |
| 29 | melanocyte differentiation (GO:0030318) | 4.45817821 |
| 30 | axon development (GO:0061564) | 4.40415460 |
| 31 | basement membrane organization (GO:0071711) | 4.40223643 |
| 32 | pigment cell differentiation (GO:0050931) | 4.39897675 |
| 33 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.39344504 |
| 34 | actin filament-based movement (GO:0030048) | 4.36701494 |
| 35 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.30448419 |
| 36 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.23611737 |
| 37 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.20293395 |
| 38 | skeletal muscle adaptation (GO:0043501) | 4.17105316 |
| 39 | regulation of gonadotropin secretion (GO:0032276) | 4.14003226 |
| 40 | response to inactivity (GO:0014854) | 4.09544943 |
| 41 | glycogen catabolic process (GO:0005980) | 4.06822683 |
| 42 | striated muscle contraction (GO:0006941) | 4.05596944 |
| 43 | neuron projection regeneration (GO:0031102) | 4.02980050 |
| 44 | negative regulation of sodium ion transport (GO:0010766) | 3.93691872 |
| 45 | short-term memory (GO:0007614) | 3.86323327 |
| 46 | regulation of response to osmotic stress (GO:0047484) | 3.85593365 |
| 47 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.84556134 |
| 48 | cardiac myofibril assembly (GO:0055003) | 3.83200653 |
| 49 | regulation of platelet aggregation (GO:0090330) | 3.82703028 |
| 50 | inositol phosphate-mediated signaling (GO:0048016) | 3.81988324 |
| 51 | glucan catabolic process (GO:0009251) | 3.76323584 |
| 52 | face development (GO:0060324) | 3.74486177 |
| 53 | cardiac muscle hypertrophy (GO:0003300) | 3.72994656 |
| 54 | negative regulation of platelet activation (GO:0010544) | 3.68269048 |
| 55 | skeletal muscle tissue development (GO:0007519) | 3.61056453 |
| 56 | response to methylmercury (GO:0051597) | 3.60418527 |
| 57 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.59491472 |
| 58 | cell-cell junction maintenance (GO:0045217) | 3.57395104 |
| 59 | striated muscle hypertrophy (GO:0014897) | 3.55733090 |
| 60 | cellular polysaccharide catabolic process (GO:0044247) | 3.53007862 |
| 61 | muscle cell migration (GO:0014812) | 3.52386329 |
| 62 | response to muscle activity (GO:0014850) | 3.52257916 |
| 63 | chondroitin sulfate catabolic process (GO:0030207) | 3.48037455 |
| 64 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.48008151 |
| 65 | muscle fiber development (GO:0048747) | 3.46414230 |
| 66 | tissue regeneration (GO:0042246) | 3.45542019 |
| 67 | negative regulation of cell-matrix adhesion (GO:0001953) | 3.45132800 |
| 68 | striated muscle adaptation (GO:0014888) | 3.42812717 |
| 69 | muscle contraction (GO:0006936) | 3.40863276 |
| 70 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.39257243 |
| 71 | regulation of plasminogen activation (GO:0010755) | 3.38292726 |
| 72 | astrocyte differentiation (GO:0048708) | 3.35957940 |
| 73 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.34018721 |
| 74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.33805540 |
| 75 | phosphate ion transmembrane transport (GO:0035435) | 3.26289424 |
| 76 | actomyosin structure organization (GO:0031032) | 3.25443130 |
| 77 | righting reflex (GO:0060013) | 3.24550677 |
| 78 | neuron remodeling (GO:0016322) | 3.24528049 |
| 79 | melanin biosynthetic process (GO:0042438) | 3.23238733 |
| 80 | syncytium formation (GO:0006949) | 3.22535474 |
| 81 | peripheral nervous system development (GO:0007422) | 3.20807140 |
| 82 | regulation of adherens junction organization (GO:1903391) | 3.16908521 |
| 83 | polysaccharide catabolic process (GO:0000272) | 3.16799193 |
| 84 | hypotonic response (GO:0006971) | 3.12635188 |
| 85 | negative regulation of leukocyte migration (GO:0002686) | 3.12329748 |
| 86 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.12321187 |
| 87 | dermatan sulfate metabolic process (GO:0030205) | 3.12019828 |
| 88 | regulation of focal adhesion assembly (GO:0051893) | 3.10688249 |
| 89 | regulation of cell-substrate junction assembly (GO:0090109) | 3.10688249 |
| 90 | muscle system process (GO:0003012) | 3.08719001 |
| 91 | hyperosmotic salinity response (GO:0042538) | 3.07709758 |
| 92 | dermatan sulfate biosynthetic process (GO:0030208) | 3.06260917 |
| 93 | muscle hypertrophy (GO:0014896) | 3.05477591 |
| 94 | fructose metabolic process (GO:0006000) | 3.04131767 |
| 95 | positive regulation of myoblast differentiation (GO:0045663) | 3.02166800 |
| 96 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.00469631 |
| 97 | terpenoid biosynthetic process (GO:0016114) | 2.98302516 |
| 98 | neural crest cell migration (GO:0001755) | 2.96348834 |
| 99 | actin filament depolymerization (GO:0030042) | 2.94949560 |
| 100 | semaphorin-plexin signaling pathway (GO:0071526) | 2.94717012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 5.00637151 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.01948180 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.61435055 |
| 4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.36034628 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.10193828 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.60713883 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.60713883 |
| 8 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.47153520 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40476601 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20063043 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.19568368 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07344417 |
| 13 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.04166123 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.03828953 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00712694 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.93790148 |
| 17 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.79956329 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.77637816 |
| 19 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.66930000 |
| 20 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.62935835 |
| 21 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.62390504 |
| 22 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.58505054 |
| 23 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.57455591 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57351947 |
| 25 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.56588624 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56255527 |
| 27 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50823641 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49309598 |
| 29 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.49269814 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.47748621 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.44388253 |
| 32 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.42981524 |
| 33 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.42112831 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40596208 |
| 35 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.40556684 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38695969 |
| 37 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.36015685 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.35294283 |
| 39 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.34757730 |
| 40 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.33632344 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32469494 |
| 42 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31344694 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28333361 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25224216 |
| 45 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22487327 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22035555 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21826739 |
| 48 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16739323 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15823361 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15399871 |
| 51 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.13309070 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13186564 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12813129 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12327351 |
| 55 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08232619 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08181489 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06625278 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02980040 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01958708 |
| 60 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99746122 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99508930 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99503959 |
| 63 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99435138 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98881382 |
| 65 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.98498039 |
| 66 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98353517 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97806482 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97790312 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97533438 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96406811 |
| 71 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.95712920 |
| 72 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94355553 |
| 73 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94273927 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93911183 |
| 75 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.92885722 |
| 76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92615324 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92335354 |
| 78 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.91908299 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.91896432 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90079339 |
| 81 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.89483484 |
| 82 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.89274152 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89270003 |
| 84 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.89240791 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89155969 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88824097 |
| 87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88592782 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86458751 |
| 89 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86174399 |
| 90 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.85563830 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84702448 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84157753 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83910174 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83132785 |
| 95 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81017817 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80851502 |
| 97 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.80736959 |
| 98 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80172930 |
| 99 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80037681 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79103158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 6.43807887 |
| 2 | MP0004036_abnormal_muscle_relaxation | 4.97432084 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.81244722 |
| 4 | MP0000749_muscle_degeneration | 3.90656095 |
| 5 | MP0004381_abnormal_hair_follicle | 3.83718832 |
| 6 | MP0000751_myopathy | 3.73683686 |
| 7 | MP0002822_catalepsy | 3.71138910 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 3.61361525 |
| 9 | MP0003646_muscle_fatigue | 3.53868488 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.34535034 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 3.29357740 |
| 12 | MP0004858_abnormal_nervous_system | 3.14068317 |
| 13 | MP0004484_altered_response_of | 2.81139879 |
| 14 | MP0005408_hypopigmentation | 2.76998499 |
| 15 | MP0005330_cardiomyopathy | 2.74290169 |
| 16 | MP0004510_myositis | 2.38147833 |
| 17 | MP0000747_muscle_weakness | 2.35981162 |
| 18 | MP0004272_abnormal_basement_membrane | 2.21881746 |
| 19 | MP0000759_abnormal_skeletal_muscle | 2.18392354 |
| 20 | MP0005620_abnormal_muscle_contractility | 2.14257398 |
| 21 | MP0005451_abnormal_body_composition | 2.13945378 |
| 22 | MP0002106_abnormal_muscle_physiology | 2.07362659 |
| 23 | MP0004087_abnormal_muscle_fiber | 2.00402056 |
| 24 | MP0002269_muscular_atrophy | 1.88396432 |
| 25 | MP0003136_yellow_coat_color | 1.87365148 |
| 26 | MP0005369_muscle_phenotype | 1.86938781 |
| 27 | MP0002108_abnormal_muscle_morphology | 1.86738033 |
| 28 | MP0005248_abnormal_Harderian_gland | 1.83121164 |
| 29 | MP0003828_pulmonary_edema | 1.80138804 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.79253873 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.75043238 |
| 32 | MP0004233_abnormal_muscle_weight | 1.70740097 |
| 33 | MP0002938_white_spotting | 1.69055028 |
| 34 | MP0006138_congestive_heart_failure | 1.65622943 |
| 35 | MP0000750_abnormal_muscle_regeneration | 1.64978557 |
| 36 | MP0002972_abnormal_cardiac_muscle | 1.64214110 |
| 37 | MP0003045_fibrosis | 1.54013292 |
| 38 | MP0000733_abnormal_muscle_development | 1.44170798 |
| 39 | MP0005503_abnormal_tendon_morphology | 1.40316140 |
| 40 | MP0010030_abnormal_orbit_morphology | 1.31425898 |
| 41 | MP0004043_abnormal_pH_regulation | 1.29242214 |
| 42 | MP0009384_cardiac_valve_regurgitation | 1.27108808 |
| 43 | MP0004130_abnormal_muscle_cell | 1.22825151 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.20949649 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.09170745 |
| 46 | MP0002751_abnormal_autonomic_nervous | 1.02725286 |
| 47 | MP0005165_increased_susceptibility_to | 0.96918374 |
| 48 | MP0005058_abnormal_lysosome_morphology | 0.96069689 |
| 49 | MP0000534_abnormal_ureter_morphology | 0.87543024 |
| 50 | MP0000013_abnormal_adipose_tissue | 0.79985275 |
| 51 | MP0010630_abnormal_cardiac_muscle | 0.79931055 |
| 52 | MP0001324_abnormal_eye_pigmentation | 0.78748639 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 0.78711488 |
| 54 | MP0005385_cardiovascular_system_phenoty | 0.78571521 |
| 55 | MP0001544_abnormal_cardiovascular_syste | 0.78571521 |
| 56 | MP0005670_abnormal_white_adipose | 0.77225632 |
| 57 | MP0000920_abnormal_myelination | 0.75951513 |
| 58 | MP0005174_abnormal_tail_pigmentation | 0.75026707 |
| 59 | MP0005257_abnormal_intraocular_pressure | 0.73874607 |
| 60 | MP0002075_abnormal_coat/hair_pigmentati | 0.70797920 |
| 61 | MP0003091_abnormal_cell_migration | 0.69894122 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.69251552 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 0.68971827 |
| 64 | MP0001661_extended_life_span | 0.68017579 |
| 65 | MP0002060_abnormal_skin_morphology | 0.66346995 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 0.65455313 |
| 67 | MP0003634_abnormal_glial_cell | 0.62916663 |
| 68 | MP0001849_ear_inflammation | 0.60185449 |
| 69 | MP0002168_other_aberrant_phenotype | 0.59218264 |
| 70 | MP0004215_abnormal_myocardial_fiber | 0.57909908 |
| 71 | MP0002896_abnormal_bone_mineralization | 0.57843118 |
| 72 | MP0008569_lethality_at_weaning | 0.57152158 |
| 73 | MP0005508_abnormal_skeleton_morphology | 0.56869544 |
| 74 | MP0001299_abnormal_eye_distance/ | 0.55492733 |
| 75 | MP0002254_reproductive_system_inflammat | 0.54630084 |
| 76 | MP0000627_abnormal_mammary_gland | 0.54393146 |
| 77 | MP0001881_abnormal_mammary_gland | 0.51586795 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.50470638 |
| 79 | MP0000003_abnormal_adipose_tissue | 0.49017137 |
| 80 | MP0001186_pigmentation_phenotype | 0.48869348 |
| 81 | MP0002114_abnormal_axial_skeleton | 0.46594007 |
| 82 | MP0008770_decreased_survivor_rate | 0.46252369 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.45394918 |
| 84 | MP0005166_decreased_susceptibility_to | 0.44749827 |
| 85 | MP0004085_abnormal_heartbeat | 0.44630633 |
| 86 | MP0003137_abnormal_impulse_conducting | 0.44516214 |
| 87 | MP0005197_abnormal_uvea_morphology | 0.44500363 |
| 88 | MP0003115_abnormal_respiratory_system | 0.42673867 |
| 89 | MP0000266_abnormal_heart_morphology | 0.41120192 |
| 90 | MP0000371_diluted_coat_color | 0.40991856 |
| 91 | MP0002282_abnormal_trachea_morphology | 0.40967984 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 0.40622051 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.39770529 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.39748236 |
| 95 | MP0005023_abnormal_wound_healing | 0.38412464 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.37182585 |
| 97 | MP0000163_abnormal_cartilage_morphology | 0.37099399 |
| 98 | MP0002116_abnormal_craniofacial_bone | 0.36520190 |
| 99 | MP0005360_urolithiasis | 0.36299481 |
| 100 | MP0001614_abnormal_blood_vessel | 0.35482216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.85201595 |
| 2 | Nemaline bodies (HP:0003798) | 7.79091914 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.66113677 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 6.41103801 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.44137368 |
| 6 | Distal lower limb muscle weakness (HP:0009053) | 5.38108882 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.26554008 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.12114179 |
| 9 | Stridor (HP:0010307) | 4.90883898 |
| 10 | Peripheral hypomyelination (HP:0007182) | 4.86620571 |
| 11 | White forelock (HP:0002211) | 4.53627393 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 4.28739258 |
| 13 | Upper limb muscle weakness (HP:0003484) | 4.22718982 |
| 14 | Hand muscle atrophy (HP:0009130) | 4.06634853 |
| 15 | Patchy hypopigmentation of hair (HP:0011365) | 4.01645498 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 3.98116218 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.97169406 |
| 18 | Increased connective tissue (HP:0009025) | 3.79440791 |
| 19 | Distal upper limb amyotrophy (HP:0007149) | 3.70548095 |
| 20 | Upper limb amyotrophy (HP:0009129) | 3.70548095 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 3.70409307 |
| 22 | Myopathic facies (HP:0002058) | 3.67428367 |
| 23 | Diaphragmatic weakness (HP:0009113) | 3.60699937 |
| 24 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.57284717 |
| 25 | Distal arthrogryposis (HP:0005684) | 3.52568477 |
| 26 | Fetal akinesia sequence (HP:0001989) | 3.42040669 |
| 27 | Neck muscle weakness (HP:0000467) | 3.36333697 |
| 28 | J-shaped sella turcica (HP:0002680) | 3.30724902 |
| 29 | Abnormal pupillary function (HP:0007686) | 3.29702135 |
| 30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.27331740 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.21067464 |
| 32 | Blue irides (HP:0000635) | 3.19988290 |
| 33 | Spinal rigidity (HP:0003306) | 3.14925182 |
| 34 | Limb-girdle muscle atrophy (HP:0003797) | 3.13606155 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.12555011 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 3.12283878 |
| 37 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.05173765 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 3.03557756 |
| 39 | Round ear (HP:0100830) | 2.98798750 |
| 40 | Asymmetric septal hypertrophy (HP:0001670) | 2.95145043 |
| 41 | Myoglobinuria (HP:0002913) | 2.94267690 |
| 42 | Rimmed vacuoles (HP:0003805) | 2.90572116 |
| 43 | Foot dorsiflexor weakness (HP:0009027) | 2.90022378 |
| 44 | Abnormal auditory evoked potentials (HP:0006958) | 2.83689601 |
| 45 | Ulnar claw (HP:0001178) | 2.79521588 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.78767652 |
| 47 | Abnormality of the foot musculature (HP:0001436) | 2.75568372 |
| 48 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.72001236 |
| 49 | Hypoplasia of the iris (HP:0007676) | 2.70762968 |
| 50 | Insidious onset (HP:0003587) | 2.64529222 |
| 51 | Termporal pattern (HP:0011008) | 2.64529222 |
| 52 | Aplasia of the musculature (HP:0100854) | 2.60413421 |
| 53 | Bulbar palsy (HP:0001283) | 2.58283469 |
| 54 | Scapular winging (HP:0003691) | 2.52928916 |
| 55 | Ulnar bowing (HP:0003031) | 2.51060698 |
| 56 | Nonprogressive disorder (HP:0003680) | 2.46298600 |
| 57 | Ulnar deviation of the wrist (HP:0003049) | 2.45924690 |
| 58 | Hypoventilation (HP:0002791) | 2.43663083 |
| 59 | Heterochromia iridis (HP:0001100) | 2.38872767 |
| 60 | Proximal amyotrophy (HP:0007126) | 2.33615728 |
| 61 | Epiphyseal dysplasia (HP:0002656) | 2.33209515 |
| 62 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.30464415 |
| 63 | Absent epiphyses (HP:0010577) | 2.30464415 |
| 64 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.29969484 |
| 65 | Steppage gait (HP:0003376) | 2.29830556 |
| 66 | Hip contracture (HP:0003273) | 2.28494988 |
| 67 | Generalized muscle weakness (HP:0003324) | 2.28362147 |
| 68 | Difficulty running (HP:0009046) | 2.26887392 |
| 69 | Slender build (HP:0001533) | 2.24200918 |
| 70 | Elbow flexion contracture (HP:0002987) | 2.22647418 |
| 71 | Lower limb amyotrophy (HP:0007210) | 2.19823148 |
| 72 | Achilles tendon contracture (HP:0001771) | 2.18167749 |
| 73 | Bundle branch block (HP:0011710) | 2.16838274 |
| 74 | Frequent falls (HP:0002359) | 2.13663670 |
| 75 | Obstructive sleep apnea (HP:0002870) | 2.13488223 |
| 76 | Muscle stiffness (HP:0003552) | 2.12878423 |
| 77 | Gowers sign (HP:0003391) | 2.12173771 |
| 78 | Long toe (HP:0010511) | 2.11046133 |
| 79 | Dilated cardiomyopathy (HP:0001644) | 2.04208417 |
| 80 | Hyperkalemia (HP:0002153) | 2.02889355 |
| 81 | Absent phalangeal crease (HP:0006109) | 2.01914140 |
| 82 | Abnormality of the umbilical cord (HP:0010881) | 2.01702158 |
| 83 | Waddling gait (HP:0002515) | 1.98341166 |
| 84 | Muscular dystrophy (HP:0003560) | 1.96943095 |
| 85 | Action tremor (HP:0002345) | 1.95330609 |
| 86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93706949 |
| 87 | Down-sloping shoulders (HP:0200021) | 1.93213023 |
| 88 | Onion bulb formation (HP:0003383) | 1.91693093 |
| 89 | Small epiphyses (HP:0010585) | 1.91403673 |
| 90 | Limited hip movement (HP:0008800) | 1.90781331 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 1.90011227 |
| 92 | Flat acetabular roof (HP:0003180) | 1.85427596 |
| 93 | Generalized amyotrophy (HP:0003700) | 1.84723548 |
| 94 | Underdeveloped nasal alae (HP:0000430) | 1.83174187 |
| 95 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.82054337 |
| 96 | Deformed sella turcica (HP:0002681) | 1.80229254 |
| 97 | Alacrima (HP:0000522) | 1.80209654 |
| 98 | Hypopigmentation of the fundus (HP:0007894) | 1.79522984 |
| 99 | Areflexia of lower limbs (HP:0002522) | 1.78760140 |
| 100 | Hypoplastic ischia (HP:0003175) | 1.77699626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.57911348 |
| 2 | PHKG2 | 5.14838233 |
| 3 | PHKG1 | 5.14838233 |
| 4 | MAP3K3 | 4.76338800 |
| 5 | LMTK2 | 4.06936599 |
| 6 | TTN | 3.20055683 |
| 7 | ERBB4 | 2.88507566 |
| 8 | MUSK | 2.62259635 |
| 9 | NME2 | 2.41994413 |
| 10 | DDR2 | 2.19756579 |
| 11 | EPHB1 | 1.85841661 |
| 12 | PAK4 | 1.62515598 |
| 13 | TRIB3 | 1.56280979 |
| 14 | RIPK1 | 1.46655819 |
| 15 | MOS | 1.43643080 |
| 16 | ICK | 1.41890825 |
| 17 | LIMK1 | 1.41352950 |
| 18 | MAP3K7 | 1.28335244 |
| 19 | PIK3CG | 1.25744983 |
| 20 | MAPKAPK3 | 1.14394414 |
| 21 | SIK3 | 1.12400159 |
| 22 | SIK1 | 1.09519139 |
| 23 | PRKD3 | 1.02496403 |
| 24 | MAPK12 | 1.01406081 |
| 25 | PIK3CA | 0.97805413 |
| 26 | PTK2B | 0.93115204 |
| 27 | MAP2K3 | 0.89572397 |
| 28 | PTK2 | 0.84872322 |
| 29 | GSK3A | 0.83388976 |
| 30 | AKT3 | 0.82544187 |
| 31 | MET | 0.79870792 |
| 32 | PDPK1 | 0.77276540 |
| 33 | PRKAA2 | 0.75522856 |
| 34 | MAP2K6 | 0.74169450 |
| 35 | PDGFRA | 0.72095966 |
| 36 | CDK12 | 0.71396903 |
| 37 | RET | 0.70958876 |
| 38 | TYRO3 | 0.70399688 |
| 39 | PAK6 | 0.70270070 |
| 40 | FER | 0.69300766 |
| 41 | ERN1 | 0.66477250 |
| 42 | PRKD2 | 0.65086939 |
| 43 | DYRK1A | 0.64254306 |
| 44 | MAP3K13 | 0.60907503 |
| 45 | FGFR4 | 0.58608360 |
| 46 | ROCK1 | 0.55826480 |
| 47 | TESK1 | 0.54244206 |
| 48 | PRKAA1 | 0.52767049 |
| 49 | PRKG2 | 0.50065070 |
| 50 | MAPK4 | 0.50014038 |
| 51 | MARK1 | 0.49479708 |
| 52 | EEF2K | 0.48149871 |
| 53 | CCNB1 | 0.46072373 |
| 54 | NME1 | 0.44549701 |
| 55 | AKT2 | 0.44409362 |
| 56 | PKN2 | 0.43624232 |
| 57 | PDK1 | 0.43580037 |
| 58 | PDGFRB | 0.41160855 |
| 59 | ERBB2 | 0.40718800 |
| 60 | FLT3 | 0.40503198 |
| 61 | ZAP70 | 0.40112285 |
| 62 | FRK | 0.39849906 |
| 63 | MARK2 | 0.39728847 |
| 64 | DMPK | 0.39270624 |
| 65 | PRKD1 | 0.39095094 |
| 66 | MAP2K1 | 0.38582435 |
| 67 | NTRK1 | 0.37448580 |
| 68 | BLK | 0.36793303 |
| 69 | NLK | 0.36224405 |
| 70 | DAPK2 | 0.36016201 |
| 71 | MARK3 | 0.35818745 |
| 72 | PINK1 | 0.35397108 |
| 73 | TRPM7 | 0.35187394 |
| 74 | MAPK11 | 0.34952741 |
| 75 | PTK6 | 0.33860201 |
| 76 | TRIM28 | 0.33400232 |
| 77 | CDK7 | 0.33359792 |
| 78 | PKN1 | 0.32183056 |
| 79 | CAMK2D | 0.30973275 |
| 80 | HCK | 0.30221302 |
| 81 | FGFR3 | 0.30085104 |
| 82 | EPHA3 | 0.29643367 |
| 83 | CDC42BPA | 0.28885373 |
| 84 | TIE1 | 0.27874576 |
| 85 | CAMK4 | 0.27622871 |
| 86 | MTOR | 0.27258167 |
| 87 | CAMK2G | 0.27149324 |
| 88 | HIPK2 | 0.26934796 |
| 89 | MAP3K6 | 0.26861981 |
| 90 | CHUK | 0.26412087 |
| 91 | ERBB3 | 0.25690011 |
| 92 | PAK1 | 0.22748126 |
| 93 | MAPK3 | 0.21746010 |
| 94 | MAPKAPK2 | 0.21425162 |
| 95 | PRKACA | 0.17459924 |
| 96 | MAPK7 | 0.16947277 |
| 97 | SGK1 | 0.15510076 |
| 98 | PRKG1 | 0.15141751 |
| 99 | FGFR2 | 0.14253235 |
| 100 | TNK2 | 0.14179142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.56229866 |
| 2 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 4.24534757 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.21938962 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.48942767 |
| 5 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.66052971 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.35259479 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.33718465 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.12210504 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.08009677 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.06270378 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.03436123 |
| 12 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.97915598 |
| 13 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.92865018 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.90820082 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.87778121 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.86790763 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81237039 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.75970297 |
| 19 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.75941027 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.72278839 |
| 21 | Lysine degradation_Homo sapiens_hsa00310 | 1.71996676 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.71839654 |
| 23 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.64538760 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61276827 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.53660225 |
| 26 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.51811371 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47682221 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42955343 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30434617 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24735251 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21131046 |
| 32 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20896981 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18204204 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18103165 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14608479 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12870179 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12438086 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06816798 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04505615 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04232989 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04036784 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01309587 |
| 43 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92971132 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 0.91783440 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 0.89933182 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86080435 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83192851 |
| 48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77992111 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74332330 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73910727 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.71234500 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68228972 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68052420 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67999875 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.66375520 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.65449324 |
| 57 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64012023 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63795081 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62053544 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61368974 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.57472786 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.56575682 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55774396 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54809199 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51149211 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50238503 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49501085 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.49211915 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48056081 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.47414108 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.47144677 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45015599 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44004010 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43533906 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42551728 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42172969 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41938190 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40503333 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40099073 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38732314 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36707570 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36238480 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35872328 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35741001 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34802043 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.34705063 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33853053 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33100495 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32674173 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.26722458 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25818849 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25065952 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.23638013 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23503701 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.21735273 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.20813028 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20790683 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19956295 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.18532518 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18031181 |

